Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
Guo Junhong,
Yu Jiangtao,
Song Xiaojie,
Mi Haixia
Affiliations
Guo Junhong
Department of Obstetrics and GynecologyWuhan Children’ Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science&Technology, Wuhan Hubei Province430016 P.R. China
Yu Jiangtao
Department of Obstetrics and Gynecology1st Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang Province325035 P.R.China
Song Xiaojie
Department of Obstetrics and GynecologyWuhan Children’ Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science&Technology, Wuhan Hubei Province430016 P.R. China
Mi Haixia
Department of Obstetrics and Gynecology of traditional Chinese Medicine, Wenzhou People’s Hospital, Wenzhou Zhejiang Province325000 P.R. China
To evaluate the diagnostic value of combination detection of serum cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA199) and carci noembryonic antigen(CEA) in patients with epithelial ovarian cancer by pooling the open published studies according to meta-analysis method.
